Active Surveillance for Cancer of the Prostate (ASCaP)
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age30-85
SponsorJonsson Comprehensive Cancer Center
About this trial
Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.
Eligibility criteria
Qualifiers
Histologically confirmed adenocarcinoma of the prostate.
Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.
No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
Patient has elected Active Surveillance as preferred management plan for prostate cancer.
Disqualifiers
Unwillingness or inability to undergo serial prostate biopsy.
Overall life expectancy less than 2 years
Advanced prostate cancer
Trial design
Treatments tested in this trial
- Active surveillance
Treatment groups
462 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov